Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.720
+0.040 (1.09%)
Nov 22, 2024, 4:00 PM EST - Market closed
Mereo BioPharma Group Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$7.50
Upside
+101.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +88.17% | Nov 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +88.17% | Oct 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +88.17% | Sep 16, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +88.17% | Aug 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +88.17% | Jul 22, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +115.05% | Jun 20, 2024 |
| Baird | Baird | Buy Initiates $8 | Buy | Initiates | $8 | +115.05% | Jun 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +88.17% | Jun 12, 2024 |
| Needham | Needham | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +88.17% | Jun 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +88.17% | May 16, 2024 |
| Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +61.29% | May 16, 2024 |
| Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +61.29% | Apr 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +88.17% | Mar 28, 2024 |
| Needham | Needham | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +61.29% | Mar 28, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +88.17% | Mar 22, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $4 | Buy | Reiterates | $4 | +7.53% | Sep 8, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.